Multiple Chemical Sensitivity (MCS) is characterised by the appearance of numerous and sometimes severe symptoms, when subjects are in contact with various chemicals and medicinal substances. Currently there are no useful guidelines for managing clinical issues and, specifically, anaesthesia for patients with MCS. This case report describes anaesthesia management in a patient affected by clinically documented MCS and a latex allergy, a candidate for a laparoscopic cholecystectomy operation.
Multiple Chemical Sensitivity (MCS), also known as Idiopathic Environmental Intolerance (lEI) syndrome indicates a particular pathological condition characterised by the inability of those affected to tolerate environments where there are different chemicals. The symptoms reported by patients usually result from their exposure to dosages of environmental chemicals or drugs normally considered non-toxic (I).
There are currently no guidelines for treating MCS (2, 3) ; it seems that one possible strategy to prevent the onset of symptoms is to protect the patient from those environmental conditions that may in some way be perceived as dangerous, as they are considered capable of triggering the onset of symptoms. The best therapeutic approach would, therefore, be to create an environment in which the subject is secure and protected from substances considered dangerous (4, 5) .
Managing patients with MCS is particularly complicated when they need hospital treatment, for various reasons, as a suitable hospital environment must be created and precise food and therapeutic indications must be followed. The need to subject a patient with MCS to general anaesthesia poses further problems, linked to an increased risk of developing adverse reactions to the anaesthetic drugs used (6) .
Case report
A 48-year-old woman (weight 60 kg, height 158 em, BMI 24.03), was hospitalised as a result of a biliary colic and was a candidate for a videolaparoscopic cholecystectomy with general anaesthesia.
At the time of the anaesthetising visit the patient, admitted to a suitably equipped, latex-free hospital room, had been the subject of extensive clinical documentation as she was suffering from "Multiple Chemical Sensitivity syndrome (MCS) with multiple medication, multiple food and rubber latex intolerance; from a type IV allergy (cellmediated) to nickel sulphate and palladium chloride with a systemic sensitivity and from intrinsic bronchial asthma". The patient traces the onset of this syndrome back to 1999 when, presumably as a result of an infectious viral episode, she took an unspecified homoeopathic drug which caused an allergic reaction. In the following years she had numerous allergic type events, documented by 36 emergency hospitalisations and characterised by symptoms such as swelling of the face, lips, and the respiratory system, asthma attacks, significant hypotensive episodes referred to as anaphylactic shock, vomiting, nausea, diarrhoea, and headaches; she was first diagnosed with MCS in 2003.
In 2004, the patient underwent a psychiatric visit where it emerged that "... in an attempt to avoid the alleged precipitants of symptoms and chemical exposures, the patient has progressively and significantly altered her own behaviour, retreating from work and interpersonal relationships and introducing a significantly restrictive diet. The findings of the tests confirm the presence of anxiety symptoms with feelings of tension, asthenia, a tendency to worry, etc. For these reasons, she was diagnosed as having a dysthymic disorder", in accordance with OMS-IV (APA), criteria for diagnosing dysthymic disorder. Her medical history showed that she had also had a bilateral maculopathy and an appendectomy operation in 1970, without any type of anaesthesia complication. Also, in 2009 the patient underwent a tooth extraction after local anaesthesia with carbocaine 2%, without any adverse effects.
A chest and heart examination did not detect any problems, and the preoperative anaesthesiologist's assessment categorised the patient as ASA-2.
The allergy specialist, consulted for the purpose of better defining the clinical situation of the patient and obtaining any procedural and therapeutic advice, reconfirmed the MCS diagnosis, based on the criteria proposed in the Consensus Document of 1999 (7) and revised in 2005 by Lacour et al. (8) , prescribed premedication with I g of hydrocortisone sodium succinate and 10 mg of chlorphenamine maleate in 250 ml ofNaCI 0.9%, I hour before the operation.
Based on the type of surgery and the patient's preference, general anaesthesia was chosen to guarantee better airway control, better analgesia and muscle relaxation. The operation was then prepared for by providing a latex-free room. Furthermore, the operating room personnel were instructed to avoid using perfumes or creams, to avoid wearing any type ofjewellery and to only wear the specially provided hypoallergenic and latex-free clothing. The walls, the floor and any electro-medical device present in the operating room were covered with hypoallergenic and latex-free sheets.
The patient was appropriately informed of all the precautions taken to make a safe operating environment in relation to the pathology presented. Routine monitoring in the operating room included: non-invasive blood pressure (NIBP), ECG with three derivations, heart rate and pulse oximetry.
The patient received 100% 02 for 3 minutes and then a 0.1 mg fentanyl citrate bolus. The general anaesthesia was induced with 0.25 mg! kg of midazolam chloride, and 0.2 mg/kg of cisatracurium besylate was used for curarisation. The choice of using midazolam as a hypnoinducing drug was dictated by the absolute certainty that the vials available were latex-free. The anaesthesia was maintained using Sevoflurane 2% for inhalation and any 0.1 mg offentanyl citrate boluses.
After endotracheal intubation, mechanical ventilation was ensured by means of a closed circuit fan (Drager-Primusg) with volumetric control (VMC) and intermittent positive pressure (IPPV). Then end-tidal carbon dioxide (ETCO 2) and airway pressure (PVA) were also monitored.
The vital signs recorded at the end showed induction: PA 105/65, FC 71 bpm, SaO 2 100%, ETC0 232 mmHg and a PYA of 14 hPa. No cutaneous manifestations or other adverse event suggesting an anaphylactic reaction were reported. A supplementary dose of 0.1 mg of fentanyl citrate was administered immediately before the incision.
Overall, the surgical phase lasted for a period of 45 minutes and during the whole period there were no significant changes in haemodynamic and/or ventilator signs, with the exclusion ofa slight increase in the PYA as a result of the pneumoperitoneum. A few minutes before the end of the operation, the patient was intravenously administered with the post-operative analgesia of 1000 mg of paracetamol and 90 mcg of buprenorphine chloride, analgesics recommended by the allergist.
When the patient woke up, after having aspired the endotracheal secretions she had control over the spontaneous recovery of her breathing. Upon awakening the patient complained of abdominal pain (NRS= 4) and was administered a supplementary dose of buprenorphine 60 meg intravenously, with satisfactory pain relief (NRS= 2). Sixty minutes after awakening she left the operating room and was transferred to her hospital room.
The patient was discharged from the hospital three days after the surgical procedure, as per the instructions of the surgeons who, considering the particular condition of the patient, preferred to err on the side of caution and extend the recovery in a protected area, for a more careful observation. Postoperative progress was defined by the surgeon as completely normal.
In a telephone follow-up 7 days after being discharged from the hospital, the patient reported being very satisfied with the care received.
DISCUSSION
There is little specific scientific documentation that indicates the safest anaesthesia behaviour in patients with MCS (9) . The risk of various kinds of often unpredictable adverse events may make a clinical assessment difficult, affect the medical examination ofthe recorded vital signs and complicate therapeutic management.
The enormous variety and vagueness of the symptoms reported by patients diagnosed with MCS contribute to making it difficult to define, at least as a clearly-defined organic pathology: by comparing the various studies where the events reported by patients with MCS are collected, it seems that patients are not hesitant with the same symptoms or the same response to the same substance.
Also the pathogenetic mechanisms remain largely unknown (10) : recent studies indicate contact with airborne chemicals (11) as the cause of symptoms that would induce mechanisms of sensitivity of the central nervous system which would follow classic symptoms of psychological conditioning (12, 13) . The association of this pathological condition with psychiatric disorders (14) , such as depression and anxiety, suggests the hypothesis that MCS belongs to the spectrum of somatoform disorders (15) .
Several studies show that subjects suffering from MCS when exposed to active or fictitious substances during provocation tests, are unable to distinguish which of the two trigger the symptoms, estimating that the mechanisms that are subject to the onset of the symptoms are, however, related to the psychic realm. In these subjects a condition would be generated for which the adverse reactions are reported in situations or environments identified by the patient as dangerous for their condition, similar to those in which the same symptoms have previously occurred (10) .
Inthis clinical case, the referenced and documented MCS required careful clinical management. The variety of substances that could potentially trigger the syndrome had, in fact, made any assessment and anaesthesia planning difficult.
The special attention paid to the patient, explained accordingly, for removing any agent that could potentially trigger symptoms from the hospital room and from the operating room, meant that she could assess, appreciate and feel safe and protected in the hospital environment, by reducing the emotional stress that could trigger MSC events. This would strengthen the hypothesis that a fundamental criterion for managing a patient suffering from MSC, also from the point of view of anaesthesia, could be to protect the patient from the conditions that stimulate their perception of recognising, even in the hospital environment, stimuli that elicit the symptoms (4).
